Member Info for maximillion69

Congressman Gus Bilirakis (FL-09): “One important tool in promoting drug development is the FDA's Rare Pediatric Disease Designation and Priority Review Voucher Program, which has led to the approval of over 50 treatments for 39 different rare, pediatric diseases - 36 of which had no FDA approval treatments before the program began. I was very pleased to see the president's FDA budget allocate funding for this priority review voucher program, and I have bipartisan legislation that would fully reauthorize the program for years to come.”

Https://energycommerce.house.gov/posts/health-subcommittee-holds-hearing-on-hhs-fiscal-year-2026-budget

Just looking at the awards to Mona it suggests for past and future work. The study may not have happened yet .

Shrek

Great digging , I’m presuming they have answers either way just hope it’s for the good

Thanks

Max

Is this data that’s required from the Phase 1

Hence the time taken ?

Does the novel antineoplastic compound, gallium maltolate cause neurological dysfunction in developing brain?

😞

There was another young face I hadn’t seen maybe others had ?

https://www.linkedin.com/in/jonah-ebent-077a012a4?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app

Https://www.linkedin.com/posts/miguel-lock_this-week-i-had-the-opportunity-to-work-at-activity-7342182554499768322-TMwL?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://trials.teamjackfoundation.org/trials/NCT06404034

https://youtu.be/7walUDYC1G8?si=vbrfjXQmz0l89CW9

CNPV vouchers will be valid through changes in a company’s ownership, though they must be used within two years of being received.

Hi Tyke

My take is the company can be sold with the Voucher included .

Https://www.pharmaceutical-technology.com/news/fda-creates-new-priority-review-voucher-scheme-to-boost-us-interests/

Thanks Howdlep

How do they drop so much on minimal trades ?

Https://x.com/imgbiometrics/status/1934602707005792489?s=46

Https://x.com/imgbiometrics/status/1933521134856675411?s=46

Https://www.proactiveinvestors.co.uk/companies/news/1072850/imaging-biometrics-to-revise-fda-application-for-brain-cancer-drug-after-positive-feedback-1072850.html

Shrek

I suppose the meeting with FDA for Phase 2 would have had new meaning with BTD , let’s hope IBAI can turn this around quicker .

FDA advised review on RPDD application ,

As Tyke says it’s not a NO , just help us out with a bit more Data then it’s a yes !

Who’s gonna take one for the team and sell a few!

Only way this will move , personally I’ve done it many times, it seems to work !